We've known about the potential effectiveness of the drug for 1.5 years and In Vitro effectiveness for 1.2 years.
The lack of large completed trials for an off patent medicine should be a black eye for the NIH.
The lack of large completed trials for an off patent medicine should be a black eye for the NIH.
Ivermectin is an anti-parasite drug. It is not an anti-viral. There is no theory for a mechanism of action for why it would be effective against COVID. There is some laboratory evidence that Ivermectin at very high concentrations can inhibit replication of COVID-19 and other viruses. The problem with this is that extrapolating from those concentrations to a dosing regimen means a dose of Ivermectin far, far higher than the dosage of Ivermectin given in humans.
So, without sufficient evidence, there's no compelling reason to do a large trial of Ivermectin.